Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild to moderate COVID-19

Our Bureau

Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients. With severe shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral […]

OptraSCAN Announces CytoSiA – A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing

Our Bureau

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening […]

Swades Foundation mobilizes INR 15 Cr worth of COVID aid

Our Bureau

Mumbai: Ronnie & Zarina Screwvala founded Swades Foundation commits big in the fight against COVID-19. Many prominent corporate and individuals have come forward and partnered with the foundation and contributed to its ‘Swades COVID-19 Relief & Recovery Fund’. The special Relief Fund is setup by the Screwvala’s to cater not just the immediate relief but also recovery of those economically impacted by […]

ChickP Announces Strategic Asia-Pacific Initiative

Our Bureau

Israel — foodTech start-up ChickP Protein, Ltd. is expanding into Asia Pacific with the launch of a new office in Singapore. The strategic move is in response to the rapidly growing demand for plant-based products in the region. The new subsidiary will bring the start-up closer to its Asian customers […]

Microba Life Sciences and Illumina partner to accelerate microbiome research

Our Bureau

Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies to advance understanding of the human gut microbiome in human health and disease. The partnership will bring together Microba’s high-quality proprietary gut microbiome analysis platform […]

Subscribe Now